Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
363-02-002 ISMRM Abstract

The Value of ADC₁₀ from Global Histogram Analysis in Differentiating Borderline from Malignant Epithelial Ovarian Tumors

Primary: Body - Pelvis
Secondary: Diffusion - DWI/DTI/DKI
363-02-002 · All About Diffusion · Monday, 11 May, 9:15 AM–10:10 AM · Digital Posters Row D
Keywords: Ovarian Tumors ADC Borderline epithelial ovarian tumors Malignant epithelial ovarian tumors
Accepted
Shaomin Li 1, Meiying Cheng2, Yimeng Cao2
1Department of Radiology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Presenting Author: Shaomin Li

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Li HM, Zhao SH, Qiang JW, et al. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression[J]. J Magn Reson Imaging, 2017, 46:1499-1506. DOI: 10.1002/jmri.25689 [doi]
2. Rizzo, S., De Piano, F., Buscarino, V., Pagan, E., Bagnardi, V., Zanagnolo, V., Colombo, N., Maggioni, A., Del Grande, M., Del Grande, F., Bellomi, M., & Aletti, G. (2020). Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study. European journal of radiology, 123, 108786. https://doi.org/10.1016/j.ejrad.2019.108786 [doi]
3. Winfield, J. M., Wakefield, J. C., Brenton, J. D., AbdulJabbar, K., Savio, A., Freeman, S., Pace, E., Lutchman-Singh, K., Vroobel, K. M., Yuan, Y., Banerjee, S., Porta, N., Ahmed Raza, S. E., & deSouza, N. M. (2021). Biomarkers for site-specific response to neoadjuvant chemotherapy in epithelial ovarian cancer: relating MRI changes to tumour cell load and necrosis. British journal of cancer, 124(6), 1130–1137. https://doi.org/10.1038/s41416-020-01217-5 [doi]
4. Türkoğlu, S., & Kayan, M. (2020). Differentiation between benign and malignant ovarian masses using multiparametric MRI. Diagnostic and interventional imaging, 101(3), 147–155. https://doi.org/10.1016/j.diii.2020.01.006 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/363-02-002